Viridian Therapeutics (VRDN)
(Delayed Data from NSDQ)
$13.47 USD
-1.37 (-9.23%)
Updated Sep 5, 2024 04:00 PM ET
After-Market: $13.48 +0.01 (0.07%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth D Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
11/11/2024
Time: -- |
9/2024 | $-1.10 | 0.00% |
Earnings Summary
For their last quarter, Viridian Therapeutics (VRDN) reported earnings of -$1.02 per share, missing the Zacks Consensus Estimate of -$0.87 per share. This reflects a negative earnings surprise of 17.24%. Look out for VRDN's next earnings release expected on November 11, 2024. For the next earning release, we expect the company to report earnings of -$1.10 per share, reflecting a year-over-year decrease of .92%.
Earnings History
Price & Consensus
Zacks News for VRDN
Strength Seen in Viridian Therapeutics (VRDN): Can Its 8.7% Jump Turn into More Strength?
VRDN: What are Zacks experts saying now?
Zacks Private Portfolio Services